Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1900082	培重组人成纤维细胞生长因子21注射液		Injection	Biological Products(1)	New Drug Application	2019-08-01	天士力生物医药股份有限公司	Shanghai Tasly Pharmaceutical Co Ltd	In Review	2019-07-30	view
CXSL2000019	重组全人源抗PCSK9单克隆抗体注射液		Injection	Biological Products(1)	New Drug Application	2020-02-14	天士力生物医药股份有限公司	Shanghai Tasly Pharmaceutical Co Ltd	In Review	2020-02-13	view
CXSS2100013	注射用重组人尿激酶原	recombinant human pro-urokinase	Lyophilized	Biological Products(2.2)	New Drug Application	2021-02-03	天士力生物医药股份有限公司	Shanghai Tasly Pharmaceutical Co Ltd	In Review	2021-02-02	view
CYSB1900006	注射用重组人尿激酶原	recombinant human pro-urokinase	Lyophilized	Biological Products	Supplementary Application	2019-01-23	天士力生物医药股份有限公司	Shanghai Tasly Pharmaceutical Co Ltd	Certificate Issued	2020-03-13	view
CYSB2000040	注射用重组人尿激酶原	recombinant human pro-urokinase	Lyophilized	Biological Products	Supplementary Application	2020-03-12	天士力生物医药股份有限公司	Shanghai Tasly Pharmaceutical Co Ltd	In Review	2020-03-11	view